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Abstract: The research was carried out between October 2005 and May 2006 on 17 donkeys of a total 
population of 98, towards establishing the therapeutic value of membendazole (MBZ) in strongyloidosis, has 
shown that this drug did not have a significant influence on the epidemiology of this particular parasitic disease. 
Post therapeutic levels of prevalence reached 100% (in May17.46% eggs per gram - EPG; 0 larva per gram - 
LPG) the intensity being of 252.9 EPG - 3964.70 LPG. These values highlight the reduce efficiency of MBZ. In 
vitro determinations shown that Egg Hatching Assay (EHA) and Larva Development Assay (LDA) for the 
therapeutic efficiency of these tests warn of the susceptibility of strongyl population to develop resistance 




Epidemiological studies referring to transmissible disease of animals require knowledge 
of the pathogens, methods of dissemination (spreading) of the infecting elements, mechanisms 
of transmission, and levels of susceptibility of the exposed individuals [Toma et al,.2000; 
Euzeby, 2002]. Through statistical and mathematical approach of the development of parasitic 
disease, implicitly strongyloidois, different epidemiological aspects can be determined as: 
statistical correlations between favorable circumstances, risk factors and the actual 
development of the disease; moment of introduction and the rate of dispersal of the parasite in 
the population; probability of diagnosis and expansion of the pathogen in known hotbeds. 
[Coles et al., 1992; Mayer et al., 1993; French and Berriatua, 2000 ; Cozma et al 2001]. 
 
MATERIAL AND METHOD 
 
Research has been carried out between October 2005 and May 2006 on a sample of 17 
donkeys out of a population of 98 from Sânmihaiu Almasului, jud Salaj. The sample consisted 
17.34% of the total population and was made out of donkeys between 6 months and 25 years. 
In this location very few donkeys benefit from de-worming treatments, simultaneously with 
horses, at the owner’s request. 
For de-warming Triclorfon and Albendazole (ABZ) based products are used, treatment 
taking place once a year. The donkeys that made up the sample have been treated in March 
with MBZ administered in doses of 7.5mg/kg. Post-therapy the values of descriptive 
epidemiological indicators have been followed (prevalence rate) and the monthly level of 
intensity [Toma et al 2000]. Therapeutic effectiveness was established in vitro using EHA and 




RESULTS AND DISCUSSIONS  
 
Oscillations in the descriptive epidemiological factors as well as the situation of the 
parasitism were slightly influenced by the de-worming treatment done in March 2006. 
If we follow the monthly dynamics of prevalence and intensity differences can be 
noticed in the levels of EPG and LPG. 
In March, before treatment, the prevalence rate was of 88.23% EPG, and 100% LPG, 
and incidence rate was of 11.76% EPG, 0 for LPG. In the same time the intensity of the 
parasitism intensity values were of 1594.11 EPG and 0 LPG (table 1). 
 
 
The epidemiological parameter evolution of strongylidosis from donkeys 
Table 1 
PERIOD  2005 - 2006 – EPG Epidemiological parameter 
October  November December January   February March April Mai 
Monthly Prevalence (no.) 14 12 17 15 14 15 14 17 
Monthly Prevalence Rate (%) 82,35 70,58 100 88,23 82,35 88,23 82,35 100 
Mean intensivity 764,7 923,52 1017,64 982,35 1323,52 1594,11 1652,94 2252,94 
PERIOD  2005 - 2006 – LPG Epidemiological parameter 
October  November December January   February March April Mai 
Monthly Prevalence (no.) 17 17 17 13 17 17 16 17 
Monthly Prevalence Rate (%) 100 100 100 76,47 100 100 94,11 100 
Mean intensivity 1947,05 2926,47 3152,94 2518,82 682,35 7382,35 4900 3964,70 
 
 
Post-therapy, in April, a slight decreasing tendency was noticed in all studied parameters 
(table 1) with the exception of intensity expressed through EPG, which shown a slightly 
increasing curve. The situation changed in May when the monthly prevalence rate (EPG, 
LPG) reached maximum once again (100%). The dynamics of intensity shown an increase of 
the values for EPG, while, LPG shown a slight decrease. Thus, intensity EPG increased from 
1652.94 in April to 2252.94 in May. This contradiction of the post-treatment values of EPG 
and LPG, can be explained by the benzimidazoles (BZ), MBZ included, property of inhibiting 
β-tubulin dependent mechanisms in the microtubs of developing eggs, which inhibits the 
hatching of the larva [Lacey et al., 1987; Lacely, 1990]. Evan whit this in mind, the post-
treatment recorded level of intensity we consider as being relatively high, showing the 
reduced effectiveness of MBZ in strongyloidosis in analyzed donkeys. This had been the main 
argument for in vitro testing of benzimidazols (BZ) through the international acclaimed tests 
as EHA and LDA. 
The hatching percentage on the EHA outlined varied values according to the studied 
substance (table2). In MBZ and ABZ (albendazole) hatching percentage was maximum even 
at 0.15µg/ml. for FBZ (fenbendazole) of the same concentration the hatching percentage was 
of 70. If an interpretation is to be made only from these results the strongyl population is to be 
considered as resistant. However in light of the fact that the average percentage in the 
whiteness sample was of 90.27%, values obtained through statistical analysis whit the help of 








          Strongyls eggs hatching percentage on  solution of  TBZ (thiabendazole), MBZ, FBZ and ABZ 
 Table 2 
Thiabendazole Mebendazole Fenbendazole Albendazole Conc. 
(µg/ml) O OL T % O OL T % O OL T % O OL T % 
5,0000 80 0 80 0,00 90 0 90 0,00 50 10 60 16,67 150 0 150 0,00 
2,5000 100 0 100 0,00 30 40 70 57,14 90 30 120 25,00 90 0 90 0,00 
1,2500 150 0 150 0,00 0 50 50 100,00 40 60 100 60,00 130 20 150 13,33 
0,6250 40 0 40 0,00 10 70 80 87,50 30 40 70 57,14 30 80 110 72,73 
0,3125 50 0 50 0,00 0 110 110 100,00 20 60 80 75,00 40 70 110 63,64 
0,1563 90 0 90 0,00 0 90 90 100,00 30 70 100 70,00 0 60 60 100,00 
0,0781 150 0 150 0,00 10 90 100 90,00 0 60 60 100,00 0 130 130 100,00 
0,0391 90 20 110 18,18 0 120 120 100,00 80 40 120 33,33 0 80 80 100,00 
0,0195 80 20 100 20,00 20 70 90 77,78 0 60 60 100,00 10 130 140 92,86 
0,0098 0 40 40 100,00 20 130 150 86,67 0 110 110 100,00 0 230 230 100,00 
0,0049 10 100 110 90,91 0 120 120 100,00 10 90 100 90,00 0 110 110 100,00 
H2O 10 120 130 96,15 10 60 70 76,19 10 130 140 96,43 0 70 70 92,31 
HCl 0 40 40 100,00 30 60 90 66,67 0 70 70 100,00 20 110 130 84,62 
General mean of hatching percentage on control samples = 90,27 
a B a b a b a b 
-445,94 50,07 -34,41 94,37 -67,89 84,30 7,14 93,67 
% of hatching at 0,15µg/ml 
-16,82 89,21 74,12 94,74 
LC50 



















-2179,63 -77,68 -255,15 129,37 
O = eggs;    OL = eggs and larvae    % = hatching percentage; T = total eggs, develop eggs and larvae. 
 
 
Thus, even if the hatching percentage is maintained over 50 in all three substances 
(ABZ-94.74%; MBZ - 89.21%; FBZ - 74.12%) values for the “Y” parameter indicated 
susceptibility of resistance phenomenon in strongyl population. For example, in MBZ the 
regression curve showed a slight negative tendency (Y= -77.68), so the strongyl population is 
susceptible to resistance. Test results from FBZ are interpreted in the same manner, the 
regression curve showed a negative tendency (Y= -225.15), the hatching percentage being 
over 50%, that shows the strongyl population being susceptible to resistance. In ABZ, the 
hatching percentage of 94.74 was directly correlated with the positive regression curve that 
shows the strongyl population being susceptible to resistance for this substance. 
Analysis of this data as a hole indicates that the prolonged usage of BZ derivatives in 
donkey and horse populations has determined the formation of resistant strongyl strains. This 
fact being confirmed by the larva development test results. Data from this test reflect the 
formation stage three larva even the maximum admitted concentration (5µg/ml) for TBZ and 
ABZ. In MBZ and FBZ testing stage three larva formed solution of 2.5µg/ml. the reduced 
effectiveness of these substances determined negative CMI values which reflect adaptation of 








Development of the third stage larva  on TBZ, MBZ, FBZ and ABZ solution 
Table 3  
Thiabendazole Mebendazole Fenbendazole Albendazole Conc. 
(µg/ml) O L3 T % O L3 T % O L3 T % O L3 T % 
5,0000 110 10 120 8,33 160 0 160 0,00 110 0 110 0,00 80 10 90 11,11 
2,5000 130 10 140 7,14 100 30 130 23,08 80 40 120 33,33 110 0 110 0,00 
1,2500 140 10 150 6,67 30 120 150 80,00 90 40 130 30,77 90 30 120 25,00 
0,6250 20 90 110 81,82 50 90 140 64,29 40 40 80 50,00 40 90 130 69,23 
0,3125 10 150 160 93,75 20 110 130 84,62 20 80 100 80,00 0 70 70 100,00 
0,1563 40 90 130 69,23 20 110 130 84,62 0 160 160 100,00 40 80 120 66,67 
0,0781 40 110 150 73,33 0 120 120 100,00 0 120 120 100,00 10 120 130 92,31 
0,0391 40 110 150 73,33 0 120 120 100,00 10 100 110 90,91 0 90 90 100,00 
0,0195 0 140 140 100,00 0 60 60 100,00 0 90 90 100,00 0 100 100 100,00 
0,0098 0 140 140 100,00 10 90 100 90,00 0 110 110 100,00 0 90 90 100,00 
0,0049 0 150 150 100,00 0 110 110 100,00 10 110 120 91,67 0 100 100 100,00 
H2O 10 130 140 63,10 10 130 140 76,43 0 100 100 88,89 0 120 120 90,91 
HCl 40 20 60 8,33 60 90 150 60,00 20 70 90 0,00 20 90 110 11,11 
General mean of  larva development percentage on control samples  = 79,83 
MIC -5,2612 -1,2711 -0,9389 -1,2010 
a B a b a b a b 



















164,99 448,88 562,43 463,24 
O = eggs; L3 = 3rd stage larva; T = total eggs and L3; 
% = larva development percentage; MIC = minimum inhibitory concentration  (µg/ml) 
 
The global analysis of data the tow tests carried out in the sample of donkeys from this 
region, highlights the clear resistance of strongyl population to BZ-derivatives. Omitting 
donkeys from de-worming treatments complicates the efficient control off strongyloidosis in 
equines from the region. Regardless of the measures that would be taken to effectively control 
this disease the effects are going to be less than hoped as long as donkeys are considered 
“resistant” and do not require de-worming treatment. In this case, donkeys are going to 
represent a permanent and inexhaustible source of strongyl strains adapted and more resistant 
to specific medication [Şuteu and Cozma, 2004]. 
Only general measures of control of strongyloidosisi hat include all equines from a 
region as well as efficient management of the pasture will provide noticeable results [Beugnet, 
1998; Cernea, 2005]. In case of BZ-derivatives resistance phenomenon in strongyl population, 
as of this region, is mandatory to change de-worming BZ derivatives with other from different 
pharmacological groups, periodic testing of all equines, as well as decontaminating pastures 
and shelters. BZ derivatives based medication will only be resumed once tests show no sings 




Research carried out for establishing the effectiveness of MBZ in strongyloidosis in 
donkeys from Sânmihaiu Almasului, Jud. Salaj, shown the following: 
 
1. Treatment with MBZ applied to donkeys had no major influence in epidemiology of 
strongyloidosis; post-treatment prevalence and incidence rate were of 100% in May (17.64 
EPG; 0 LPG), while intensity was 2252.94 EPG - 3964.70 LPG. These results show the 
reduced effectiveness of MBZ treatment; 
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2. In vitro EHA and LDA tests of the effectiveness of MBZ indicate the onset of 
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